Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 428 across all filing types
Latest filing 2024-08-17 Declaration of Voting R…
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Record Date
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a notice addressed to the National Stock Exchange of India regarding the book closure and record date for the 17th Annual General Meeting (AGM) of Vaishali Pharma Limited. It specifies dates for the closure of the register of members and share transfer books, the record date for voting rights, and the e-voting period. The content is an announcement related to the administrative details of the AGM, not the AGM materials or presentations themselves. The document length is short (1754 characters), and it serves as a formal notification rather than a report or detailed presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly AGM Information (AGM-R). However, since it is about the record date and voting rights for the AGM, it aligns best with DVA, which covers official results and voting rights announcements related to shareholder meetings.
2024-08-17 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed unaudited financial results for multiple companies for the quarter ended June 30, 2024. It includes figures such as total income, net profit/loss before and after tax, comprehensive income, equity share capital, and earnings per share. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 33, which pertains to quarterly financial results. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The presence of actual financial data and analysis for a quarter strongly indicates this is an Interim / Quarterly Report. There is no indication that this is merely an announcement or a certification, nor is it a full annual report or audit report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2024-08-16 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a statement submitted to the stock exchange (BSE Limited) regarding the deviation or variation in the utilization of funds raised by the company through issuance of equity shares by conversion of warrants. It references Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details for the quarter ended June 30, 2024. The document includes a statement that there are no deviations or variations in the use of funds, reviewed by the Audit Committee and Board. This type of filing is a regulatory compliance disclosure related to fund utilization and is not a full financial report, earnings release, or management discussion. It is a specific regulatory announcement about fund usage and compliance with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-14 English
Financial Result Updates
Regulatory Filings
2024-08-14 English
Outcome of Board Meeting
Regulatory Filings
2024-08-14 English
Press Release
Regulatory Filings Classification · 95% confidence The document text is only 3133 characters long and consists almost entirely of omitted pictures and a digital signature block. There is no substantive textual content, financial data, or report narrative present. The presence of a digital signature suggests it might be a certification or attestation document. Given the lack of actual report content and the short length, this document does not appear to be a full financial report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for documents that do not fit other specific types, especially those that are short and contain certifications or signatures without substantive report content.
2024-08-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.